Nanoparticulate fibrate formulations

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S543000

Reexamination Certificate

active

07931917

ABSTRACT:
The present invention is directed to fibrate compositions having improved pharmacokinetic profiles and reduced fed/fasted variability. The fibrate particles of the composition have an effective average particle size of less than about 2000 nm.

REFERENCES:
patent: 3907792 (1975-09-01), Mieville
patent: 4250191 (1981-02-01), Edwards
patent: 4499289 (1985-02-01), Baran et al.
patent: 4540602 (1985-09-01), Motoyama et al.
patent: 4562069 (1985-12-01), Hegasy et al.
patent: 4647576 (1987-03-01), Hoefle et al.
patent: 4686237 (1987-08-01), Anderson
patent: 4783484 (1988-11-01), Violante et al.
patent: 4814175 (1989-03-01), Tack et al.
patent: 4826689 (1989-05-01), Violanto et al.
patent: 4895726 (1990-01-01), Curtet et al.
patent: 4997454 (1991-03-01), Violante et al.
patent: 5145684 (1992-09-01), Liversidge et al.
patent: 5298262 (1994-03-01), Na et al.
patent: 5302401 (1994-04-01), Liversidge et al.
patent: 5318767 (1994-06-01), Liversidge et al.
patent: 5326552 (1994-07-01), Na et al.
patent: 5328404 (1994-07-01), Bacon
patent: 5336507 (1994-08-01), Na et al.
patent: 5340564 (1994-08-01), Illig et al.
patent: 5346702 (1994-09-01), Na et al.
patent: 5349957 (1994-09-01), Yudelson
patent: 5352459 (1994-10-01), Hollister et al.
patent: 5356467 (1994-10-01), Oshlack et al.
patent: 5399363 (1995-03-01), Liversidge et al.
patent: 5401492 (1995-03-01), Kellar et al.
patent: 5429824 (1995-07-01), June
patent: 5447710 (1995-09-01), Na et al.
patent: 5451393 (1995-09-01), Liversidge et al.
patent: 5466440 (1995-11-01), Ruddy et al.
patent: 5470583 (1995-11-01), Na et al.
patent: 5472683 (1995-12-01), Illig
patent: 5494683 (1996-02-01), Liversidge et al.
patent: 5500204 (1996-03-01), Osifo
patent: 5510118 (1996-04-01), Bosch et al.
patent: 5518187 (1996-05-01), Bruno et al.
patent: 5518738 (1996-05-01), Eickhoff et al.
patent: 5521218 (1996-05-01), Osifo
patent: 5525328 (1996-06-01), Bacon et al.
patent: 5534270 (1996-07-01), De Castro
patent: 5543133 (1996-08-01), Swanson et al.
patent: 5545628 (1996-08-01), Deboeck et al.
patent: 5552160 (1996-09-01), Liversidge et al.
patent: 5560931 (1996-10-01), Eickhoff et al.
patent: 5560932 (1996-10-01), Bagchi et al.
patent: 5565188 (1996-10-01), Wong et al.
patent: 5569448 (1996-10-01), Wong et al.
patent: 5571536 (1996-11-01), Eickhoff et al.
patent: 5573749 (1996-11-01), Illig
patent: 5573750 (1996-11-01), Singh
patent: 5573783 (1996-11-01), Desieno et al.
patent: 5580579 (1996-12-01), Ruddy et al.
patent: 5585108 (1996-12-01), Ruddy et al.
patent: 5587143 (1996-12-01), Wong
patent: 5591456 (1997-01-01), Franson et al.
patent: 5593657 (1997-01-01), Ruddy et al.
patent: 5622938 (1997-04-01), Wong
patent: 5628981 (1997-05-01), Liversidge et al.
patent: 5643552 (1997-07-01), Illig
patent: 5662883 (1997-09-01), Bagchi et al.
patent: 5665331 (1997-09-01), Bagchi et al.
patent: 5718388 (1998-02-01), Czekai et al.
patent: 5718919 (1998-02-01), Ruddy et al.
patent: 5741522 (1998-04-01), Violante et al.
patent: 5747001 (1998-05-01), Wiedmann et al.
patent: 5776496 (1998-07-01), Violante et al.
patent: 5834025 (1998-11-01), de Garavilla et al.
patent: 5862999 (1999-01-01), Czekai et al.
patent: 6045829 (2000-04-01), Liversidge et al.
patent: 6068858 (2000-05-01), Liversidge et al.
patent: 6074670 (2000-06-01), Stamm et al.
patent: 6153225 (2000-11-01), Lee et al.
patent: 6165506 (2000-12-01), Jain et al.
patent: 6177103 (2001-01-01), Pace et al.
patent: 6180138 (2001-01-01), Engh et al.
patent: 6221400 (2001-04-01), Liversidge et al.
patent: 6264922 (2001-07-01), Wood et al.
patent: 6270806 (2001-08-01), Liversidge et al.
patent: 6277405 (2001-08-01), Stamm et al.
patent: 6316029 (2001-11-01), Jain et al.
patent: 6368620 (2002-04-01), Liu et al.
patent: 6368622 (2002-04-01), Chen et al.
patent: 6372251 (2002-04-01), Liu et al.
patent: 6375986 (2002-04-01), Ryde et al.
patent: 6383517 (2002-05-01), Qiu et al.
patent: 6384062 (2002-05-01), Ikeda et al.
patent: 6387409 (2002-05-01), Khan et al.
patent: 6428814 (2002-08-01), Bosch
patent: 6431478 (2002-08-01), Reed et al.
patent: 6432381 (2002-08-01), Liversidge et al.
patent: 6444225 (2002-09-01), Sherman
patent: 6451339 (2002-09-01), Patel et al.
patent: 6465011 (2002-10-01), Law et al.
patent: 6589552 (2003-07-01), Stamm et al.
patent: 6592903 (2003-07-01), Ryde et al.
patent: 6596317 (2003-07-01), Stamm et al.
patent: 6604698 (2003-08-01), Verhoff et al.
patent: 6634576 (2003-10-01), Verhoff et al.
patent: 6696084 (2004-02-01), Pace et al.
patent: 7037529 (2006-05-01), Stamm et al.
patent: 7255877 (2007-08-01), Parikh
patent: 7276249 (2007-10-01), Ryde et al.
patent: 7320802 (2008-01-01), Ryde et al.
patent: 2001/0006658 (2001-07-01), Liu et al.
patent: 2001/0053385 (2001-12-01), Lipari et al.
patent: 2002/0003179 (2002-01-01), Verhoff
patent: 2002/0012675 (2002-01-01), Jain et al.
patent: 2002/0012704 (2002-01-01), Pace et al.
patent: 2002/0056206 (2002-05-01), Pace et al.
patent: 2003/0031705 (2003-02-01), Sherman
patent: 2003/0077297 (2003-04-01), Chen et al.
patent: 2003/0194442 (2003-10-01), Guivarch et al.
patent: 2003/0224058 (2003-12-01), Ryde et al.
patent: 2004/0058009 (2004-03-01), Ryde et al.
patent: 2007/0264348 (2007-11-01), Ryde et al.
patent: 2007/0298115 (2007-12-01), Ryde et al.
patent: 2008/0095851 (2008-04-01), Ryde et al.
patent: 2008/0138424 (2008-06-01), Ryde et al.
patent: 2008/0241070 (2008-10-01), Ryde et al.
patent: 0 142 146 (1985-05-01), None
patent: 0 221 025 (1987-05-01), None
patent: 1 112 064 (2001-07-01), None
patent: 2 166 651 (1986-05-01), None
patent: WO 86/03488 (1986-06-01), None
patent: WO 86/07054 (1986-12-01), None
patent: WO 99/29300 (1999-06-01), None
patent: WO 00/16749 (2000-03-01), None
patent: WO 00/37057 (2000-06-01), None
patent: WO 00/57859 (2000-10-01), None
patent: WO 00/57918 (2000-10-01), None
patent: WO 00/72829 (2000-12-01), None
patent: WO 01/21154 (2001-03-01), None
patent: WO 01/85345 (2001-11-01), None
patent: WO 02/17883 (2002-03-01), None
patent: WO 02/24169 (2002-03-01), None
patent: WO 02/24192 (2002-03-01), None
patent: WO 02/24193 (2002-03-01), None
patent: WO 02/067901 (2002-09-01), None
patent: WO 02/098565 (2002-12-01), None
patent: WO 03/013474 (2003-02-01), None
patent: WO 03/013500 (2003-02-01), None
The Physicians' Desk Reference, 56thEd., pp. 513-516 (2002).
Lindahl et al., “Characterization of Fluids from the Stomach and Proximal Jejunum in Men and Women,”Pharm. Res., 14(4): 497-502 (1997).
Guidance for Industry, Levothyroxine Sodium Tablets-In Vivo Pharmacokinetic and Bioavailability Studies and in Vitro Dissolution Testing, U.S. Department of Health and Human Services, Food and Drug Administration, Dec. 2000, pp. 1-8.
Guivarc'h et al., “A New Fenofibrate Formulation: Results of Six Single-Dose, Clinical Studies of Bioavailablity Under Fed and Fasting Conditions,”Clinical Therapeutics, vol. 26, No. 9, 2004, pp. 1456-1469.
Office Action from related U.S. Appl. No. 11/710,607 dated Jun. 11, 2009.
Vogt et al., “Dissolution Enhancement of Fenofibrate by Micronization, Cogrinding and Spray-Drying: Comparison with Commercial Preparations,”European Journ. Of Pharm. &Biopharmaceutics, 68, pp. 283-288 (2008).
Office Action from related U.S. Appl. No. 11/710,607 dated Jan. 23, 2009, 10 pgs.
Office Action dated Oct. 29, 2009 for related U.S. Appl. No. 11/979,230.
Office Action dated Aug. 27, 2009 for related U.S. Appl. No. 11/802,542.
Office Action dated Mar. 5, 2010, for related U.S. Appl. No. 11/802,542.
Office Action dated Feb. 18, 2010, for related U.S. Appl. No. 11/710,607.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Nanoparticulate fibrate formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nanoparticulate fibrate formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanoparticulate fibrate formulations will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2671362

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.